Global wild capture fisheries have been operating at or near maximum sustainable yield for more than two decades, with the Food and Agriculture Organization estimating that over 35 percent of monitored fish stocks are exploited at biologically unsustainable levels and a further 57 percent are fished at maximum sustainable capacity, leaving aquaculture as the only mechanism through which global seafood supply can grow to meet the protein demand of a population expected to reach 10 billion by mid-century with rising per capita seafood consumption as developing country incomes increase. Aquaculture now accounts for approximately 50 percent of global seafood consumed by humans and is the fastest growing food production sector globally, with production growing from under 10 million tonnes annually in 1990 to over 90 million tonnes including aquatic plants, with the sector's geographic concentration in Asia, particularly China which produces over 60 percent of global aquaculture output, beginning to diversify as European, North American, and emerging market producers invest in higher-value species production and technology-intensive production systems that reduce the environmental footprint that has historically constrained aquaculture's social licence to operate. The commercial opportunity across salmon, shrimp, seabass and seabream, tilapia, and emerging species including yellowtail and barramundi is being reshaped by technology transitions in recirculating aquaculture systems, selective breeding programmes, fish health management, and feed ingredient innovation that are changing the economics and geography of aquaculture production.
Atlantic Salmon and the Technology Intensity Premium
Atlantic salmon aquaculture, the highest-value and most commercially sophisticated segment of global finfish farming, is dominated by Norwegian producers including Mowi, SalMar, Cermaq, and Grieg Seafood who have built vertically integrated businesses spanning selective breeding, smolt production, sea cage farming, processing, and global distribution at a scale and operational sophistication that makes Norwegian salmon aquaculture a benchmark for the industry globally. The Norwegian production system, which relies on sea cage farming in the sheltered fjords and coastal waters of western Norway, is approaching its licensed biomass limits under the Norwegian government's traffic light regulation system that restricts production capacity expansion in regions where salmon farming's environmental impact on wild salmon populations and sea lice levels exceeds defined thresholds, creating a constraint on Norwegian production growth that is driving investment in exposed site offshore cage technology, land-based recirculating aquaculture systems, and geographic diversification to aquaculture-suitable coastal waters in other countries. The commercial response to Norwegian production constraints includes Mowi and SalMar's investments in exposed site farming off the Norwegian coast, Cermaq's expansion in Canada and Chile, and the emergence of land-based RAS salmon farming companies including Atlantic Sapphire, Pure Salmon, and Nordic Aquafarms who are building large-scale indoor salmon farms in markets including the United States and Denmark that position farmed salmon production closer to consumer markets while eliminating sea lice and wild fish interaction concerns.
The economics of land-based RAS salmon farming have proven more challenging than early projections suggested, with Atlantic Sapphire's Miami facility experiencing significant operational difficulties and cost overruns that illustrate the gap between the theoretical advantages of RAS technology and the practical engineering and biological management challenges of operating land-based salmon systems at commercial scale, with the energy intensity, capital cost, and biological complexity of large-scale RAS facilities creating cost per kilogram structures that require premium pricing to generate acceptable returns.
Shrimp Aquaculture and Disease Management Challenges
Shrimp aquaculture, the largest aquaculture sector by value globally, has experienced repeated disease-driven production crises that have reshaped the geographic distribution of production away from historically dominant regions, with early mortality syndrome devastating shrimp production in Thailand, Vietnam, and China in 2012 to 2015 and shifting production toward Ecuador, which has emerged as the world's largest shrimp exporter through the rapid expansion of extensive pond farming in coastal Guayas province. The disease vulnerability of conventional shrimp pond farming to bacterial and viral pathogens including white spot syndrome virus, infectious myonecrosis virus, and Vibrio bacteria reflects the density and water quality management challenges of intensive shrimp farming systems, driving investment in specific pathogen free broodstock programmes, biosecure hatchery systems, probiotic feed additives, and biofloc technology pond management that reduce disease incidence and improve survival rates in commercial shrimp production. CP Foods in Thailand, Charoen Pokphand's integrated shrimp business, Minh Phu Seafood in Vietnam, and Omarsa in Ecuador are among the leading integrated shrimp producers whose scale, vertical integration from genetics through processing, and investment in disease management and traceability represent the commercial model toward which the industry is evolving from the more fragmented smallholder-dominated production that characterises traditional shrimp farming in Southeast Asia.
Feed Innovation and the Fishmeal Transition
The dependence of carnivorous aquaculture species including salmon, shrimp, and marine finfish on wild-caught fishmeal and fish oil as essential protein and omega-3 sources in aquaculture diets represents a sustainability constraint that the industry is addressing through feed ingredient innovation, with insect meal from black soldier fly larvae, single-cell proteins from fermentation, algal omega-3 oils, and crop-derived protein concentrates increasingly replacing fishmeal and fish oil in aquaculture diet formulations without compromising growth performance and product quality. Evonik's methionine and threonine amino acid supplements, Skretting's proprietary salmon diet formulations with reduced fishmeal inclusion, and emerging feed ingredient companies including Calysta, Innovafeed, and Protix are competing to supply the protein and omega-3 ingredients that allow aquaculture to decouple its growth from wild capture fisheries rather than simply transferring marine resource pressure from farmed to forage fish species consumed as fishmeal. The technical challenge of maintaining consumer-valued omega-3 fatty acid content in farmed fish as dietary fish oil is replaced by alternative sources is driving investment in algal omega-3 production and in selective breeding for improved omega-3 retention, as the nutritional differentiation of farmed salmon and other fatty fish species relative to other protein sources depends on maintaining the EPA and DHA content that consumers and nutritionists associate with seafood's health benefits.
Top 10 Companies in Aquaculture and Sustainable Seafood
- Mowi -- World's largest Atlantic salmon producer with fully integrated operations from genetics through global distribution, operating sea cage farming in Norway, Scotland, Canada, Chile, and Ireland with significant investment in smolt production and processing capacity.
- SalMar -- Norwegian Atlantic salmon farmer with sea cage and offshore exposed site farming investment, including the Ocean Farm 1 offshore semi-submersible cage demonstrating next-generation salmon farming technology for higher-current and more exposed coastal locations.
- CP Foods (Charoen Pokphand) -- Thai integrated food company with the world's largest shrimp aquaculture business from genetics through processing and retail, with disease management investment, SPF broodstock programmes, and processing capacity across Thailand and international operations.
- Skretting (Nutreco) -- Global aquaculture feed company supplying salmon, shrimp, and marine finfish diets with proprietary formulation and reduced fishmeal inclusion, investing in alternative protein and omega-3 ingredient integration across its aquaculture feed product range.
- Cermaq (Mitsubishi) -- Norwegian salmon farmer with operations in Norway, Canada, and Chile, owned by Mitsubishi Corporation, with selective breeding and sea lice management investment and geographic diversification across three major salmon farming regions.
- Atlantic Sapphire -- Danish-Norwegian land-based RAS salmon farming company with Bluehouse facility in Miami Florida targeting US market proximity, navigating the operational and cost challenges of large-scale indoor salmon farming while advancing the land-based aquaculture technology model.
- Innovafeed -- French insect protein company with black soldier fly larvae production for aquaculture and animal feed markets, supplying fishmeal replacement protein with Cargill investment and partnerships with salmon and shrimp feed manufacturers pursuing fishmeal reduction.
- Minh Phu Seafood -- Vietnam's largest shrimp processor and exporter with integrated shrimp farming, processing, and international distribution, targeting premium shrimp markets in the US, Japan, and Europe with traceability and sustainability certification programmes.
- Benchmark Genetics -- UK-based aquaculture genetics and health company with Atlantic salmon and shrimp selective breeding programmes, sea lice treatment products, and biosecurity services targeting the fish health and genetics segment of the aquaculture supply chain.
- Calysta -- US single-cell protein company producing FeedKind protein from natural gas fermentation as a fishmeal alternative for aquaculture diets, with Cargill partnership and commercial-scale production targeting the high-value salmon and shrimp feed ingredient market.
Our Take
Aquaculture's commercial trajectory is structurally favourable because it is the only mechanism through which seafood supply can grow at a pace consistent with demand, and the technology and sustainability improvements underway in salmon, shrimp, and marine finfish farming are real and commercially significant rather than aspirational. The Norwegian salmon industry's production constraint is a genuine market force that is driving technology investment in offshore and land-based alternatives, and the companies that solve the operational and cost challenges of these production systems at commercial scale will access production growth that sea cage licensing constraints would otherwise foreclose. The feed ingredient transition away from fishmeal dependence is both a sustainability imperative and a commercial opportunity for the ingredient companies developing viable replacements, and the aquaculture sector's scale and growth trajectory makes it one of the most commercially attractive application markets for alternative protein and omega-3 technologies. The disease management challenge in shrimp aquaculture is real and recurring, and the integrated producers who invest in genetics, biosecurity, and farm management technology to systematically reduce disease incidence will capture disproportionate share as less sophisticated competitors continue to absorb production losses that erode their competitive position. -- Marcus Reid, MarketsNXT